COMBINATION ANTI-PARATUBERCULOSIS THERAPY WITH RIFABUTIN, CLARITHROMYCIN AND CLOFAZIMINE FOR CROHNâ¿¿S DISEASE: A THREE YEAR PROSPECTIVE, RANDOMISED, PLACEBO-CONTROLLED, MULTICENTRE STUDY

Update Il y a 4 ans
Reference:

  • | Country :
  • Australia
  • | organs :
  • -
  • | Specialty :
  • -

Extract


Inclusion criteria

  • Crohn’s Disease

Links